Product Type Analysis The semaglutide segment led in 2024, claiming a market share of 58.4% owing to the clinical efficacy and widespread adoption of semaglutide-based products for both type 2 diabetes and obesity management
10.4103/jomfp.JOMFP_237_16 J Oral Maxillofac Pathol
Feel more energized When youre eating less, energy can take a hit
Prioritizing protein helps preserve (or grow) lean muscle mass (especially important on a calorie reduction), maintain strength, and support healthy aging during weight loss
Hypothalamic digoxin, hemispheric chemical dominance, and Alzheimer's disease
Without rigorous, peer-reviewed clinical trials, the long-term behaviour of these substances within the body remains less clear than that of MHRA-approved medications